1. AMGEN (2018) Enbrel® (etanercept).
https://www.enbrel.com/
. Accessed 10 Jul 2018.
2. National Institute for Health and Clinical Excellence (2006) Adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis.
3. Bonafede MMK, Gandra SR, Watson C, Princic N, Fox KM. Cost per treated patient for etanercept, adalimumab, and infliximab across adult indications: a claims analysis. Adv Ther. 2012;29:234–48.
4. Norman P. Enbrel and etanercept biosimilars: a tale of two patent systems. Pharm Pat Anal. 2017;6:5–7.
5. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) C for BE and R (CBER). (2015) Scientific Considerations in Demonstrating Biosimilarity to a Reference Product Guidance for Industry.